Bath & Body Works (NYSE:BBWI - Get Free Report) will likely be releasing its Q2 2026 results before the market opens on Thursday, August 28th. Analysts expect Bath & Body Works to post earnings of $0.36 per share and revenue of $1.5521 billion for the quarter. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS.Interested persons may visit the the company's upcoming Q2 2026 earningresults page for the latest details on the call scheduled for Thursday, August 28, 2025 at 8:30 AM ET.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the prior year, the business posted $0.38 EPS. The company's quarterly revenue was up 2.9% on a year-over-year basis. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Bath & Body Works Trading Up 5.6%
Shares of Bath & Body Works stock traded up $1.6350 during trading hours on Friday, reaching $31.0550. 4,792,107 shares of the company's stock were exchanged, compared to its average volume of 4,610,963. The company has a 50 day moving average of $30.30 and a two-hundred day moving average of $30.97. Bath & Body Works has a fifty-two week low of $24.94 and a fifty-two week high of $41.87. The stock has a market cap of $6.57 billion, a P/E ratio of 8.28, a P/E/G ratio of 1.04 and a beta of 1.54.
Bath & Body Works Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 21.33%.
Wall Street Analyst Weigh In
A number of research firms have recently commented on BBWI. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Morgan Stanley dropped their target price on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. UBS Group upped their target price on shares of Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a report on Thursday. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $42.06.
Get Our Latest Analysis on Bath & Body Works
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of BBWI. Royal Bank of Canada raised its holdings in Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company's stock valued at $1,815,000 after acquiring an additional 28,815 shares during the period. Goldman Sachs Group Inc. raised its holdings in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company's stock valued at $19,586,000 after acquiring an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company's stock valued at $17,063,000 after acquiring an additional 36,684 shares during the period. Intech Investment Management LLC bought a new position in Bath & Body Works in the 1st quarter valued at about $1,155,000. Finally, Geneos Wealth Management Inc. raised its holdings in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after acquiring an additional 801 shares during the period. 95.14% of the stock is owned by institutional investors.
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access